1186 related articles for article (PubMed ID: 29642940)
41. Colorectal cancer diagnostic model utilizing metagenomic and metabolomic data of stool microbial extracellular vesicles.
Kim DJ; Yang J; Seo H; Lee WH; Ho Lee D; Kym S; Park YS; Kim JG; Jang IJ; Kim YK; Cho JY
Sci Rep; 2020 Feb; 10(1):2860. PubMed ID: 32071370
[TBL] [Abstract][Full Text] [Related]
42. Parvimonas micra as a putative non-invasive faecal biomarker for colorectal cancer.
Löwenmark T; Löfgren-Burström A; Zingmark C; Eklöf V; Dahlberg M; Wai SN; Larsson P; Ljuslinder I; Edin S; Palmqvist R
Sci Rep; 2020 Sep; 10(1):15250. PubMed ID: 32943695
[TBL] [Abstract][Full Text] [Related]
43. Meta-analyses of host metagenomes from colorectal cancer patients reveal strong relationship between colorectal cancer-associated species.
Riveros Escalona MA; Poloni JF; Krause MJ; Dorn M
Mol Omics; 2023 Jun; 19(5):429-444. PubMed ID: 37039269
[TBL] [Abstract][Full Text] [Related]
44. Fecal Bacteria Act as Novel Biomarkers for Noninvasive Diagnosis of Colorectal Cancer.
Liang Q; Chiu J; Chen Y; Huang Y; Higashimori A; Fang J; Brim H; Ashktorab H; Ng SC; Ng SSM; Zheng S; Chan FKL; Sung JJY; Yu J
Clin Cancer Res; 2017 Apr; 23(8):2061-2070. PubMed ID: 27697996
[No Abstract] [Full Text] [Related]
45. Structural segregation of gut microbiota between colorectal cancer patients and healthy volunteers.
Wang T; Cai G; Qiu Y; Fei N; Zhang M; Pang X; Jia W; Cai S; Zhao L
ISME J; 2012 Feb; 6(2):320-9. PubMed ID: 21850056
[TBL] [Abstract][Full Text] [Related]
46. A Simple and Novel Fecal Biomarker for Colorectal Cancer: Ratio of
Guo S; Li L; Xu B; Li M; Zeng Q; Xiao H; Xue Y; Wu Y; Wang Y; Liu W; Zhang G
Clin Chem; 2018 Sep; 64(9):1327-1337. PubMed ID: 29914865
[TBL] [Abstract][Full Text] [Related]
47. Gut mucosal microbiome across stages of colorectal carcinogenesis.
Nakatsu G; Li X; Zhou H; Sheng J; Wong SH; Wu WK; Ng SC; Tsoi H; Dong Y; Zhang N; He Y; Kang Q; Cao L; Wang K; Zhang J; Liang Q; Yu J; Sung JJ
Nat Commun; 2015 Oct; 6():8727. PubMed ID: 26515465
[TBL] [Abstract][Full Text] [Related]
48. Role of the Gut Microbiota and Its Metabolites in Tumorigenesis or Development of Colorectal Cancer.
Qu R; Zhang Y; Ma Y; Zhou X; Sun L; Jiang C; Zhang Z; Fu W
Adv Sci (Weinh); 2023 Aug; 10(23):e2205563. PubMed ID: 37263983
[TBL] [Abstract][Full Text] [Related]
49. The association between fecal microbiota and different types of colorectal polyp as precursors of colorectal cancer.
Rezasoltani S; Asadzadeh Aghdaei H; Dabiri H; Akhavan Sepahi A; Modarressi MH; Nazemalhosseini Mojarad E
Microb Pathog; 2018 Nov; 124():244-249. PubMed ID: 30142468
[TBL] [Abstract][Full Text] [Related]
50. Metagenome Analysis of Intestinal Bacteria in Healthy People, Patients With Inflammatory Bowel Disease and Colorectal Cancer.
Ma Y; Zhang Y; Xiang J; Xiang S; Zhao Y; Xiao M; Du F; Ji H; Kaboli PJ; Wu X; Li M; Wen Q; Shen J; Yang Z; Li J; Xiao Z
Front Cell Infect Microbiol; 2021; 11():599734. PubMed ID: 33738265
[TBL] [Abstract][Full Text] [Related]
51. Using gut microbiota as a diagnostic tool for colorectal cancer: machine learning techniques reveal promising results.
Lu F; Lei T; Zhou J; Liang H; Cui P; Zuo T; Ye L; Chen H; Huang J
J Med Microbiol; 2023 Jun; 72(6):. PubMed ID: 37288545
[No Abstract] [Full Text] [Related]
52. Metagenomic analyses of the gut microbiota associated with colorectal adenoma.
Saito K; Koido S; Odamaki T; Kajihara M; Kato K; Horiuchi S; Adachi S; Arakawa H; Yoshida S; Akasu T; Ito Z; Uchiyama K; Saruta M; Xiao JZ; Sato N; Ohkusa T
PLoS One; 2019; 14(2):e0212406. PubMed ID: 30794590
[TBL] [Abstract][Full Text] [Related]
53. Quantitation of faecal
Wong SH; Kwong TNY; Chow TC; Luk AKC; Dai RZW; Nakatsu G; Lam TYT; Zhang L; Wu JCY; Chan FKL; Ng SSM; Wong MCS; Ng SC; Wu WKK; Yu J; Sung JJY
Gut; 2017 Aug; 66(8):1441-1448. PubMed ID: 27797940
[TBL] [Abstract][Full Text] [Related]
54. Metagenomic analysis of the gut microbiome in atherosclerosis patients identify cross-cohort microbial signatures and potential therapeutic target.
Liu S; Zhao W; Liu X; Cheng L
FASEB J; 2020 Nov; 34(11):14166-14181. PubMed ID: 32939880
[TBL] [Abstract][Full Text] [Related]
55. Progress of gut microbiome and its metabolomics in early screening of colorectal cancer.
Zhou L; Jiang Z; Zhang Z; Xing J; Wang D; Tang D
Clin Transl Oncol; 2023 Jul; 25(7):1949-1962. PubMed ID: 36790675
[TBL] [Abstract][Full Text] [Related]
56. Metagenomic analysis of the interaction between the gut microbiota and colorectal cancer: a paired-sample study based on the GMrepo database.
Chen H; Jiao J; Wei M; Jiang X; Yang R; Yu X; Zhang G; Zhou X
Gut Pathog; 2022 Dec; 14(1):48. PubMed ID: 36564826
[TBL] [Abstract][Full Text] [Related]
57. 16S rRNA of Mucosal Colon Microbiome and CCL2 Circulating Levels Are Potential Biomarkers in Colorectal Cancer.
Nardelli C; Granata I; Nunziato M; Setaro M; Carbone F; Zulli C; Pilone V; Capoluongo ED; De Palma GD; Corcione F; Matarese G; Salvatore F; Sacchetti L
Int J Mol Sci; 2021 Oct; 22(19):. PubMed ID: 34639088
[TBL] [Abstract][Full Text] [Related]
58. Gut microbiota imbalance and colorectal cancer.
Gagnière J; Raisch J; Veziant J; Barnich N; Bonnet R; Buc E; Bringer MA; Pezet D; Bonnet M
World J Gastroenterol; 2016 Jan; 22(2):501-18. PubMed ID: 26811603
[TBL] [Abstract][Full Text] [Related]
59. Altered gut microbiome composition by appendectomy contributes to colorectal cancer.
Shi F; Liu G; Lin Y; Guo CL; Han J; Chu ESH; Shi C; Li Y; Zhang H; Hu C; Liu R; He S; Guo G; Chen Y; Zhang X; Coker OO; Wong SH; Yu J; She J
Oncogene; 2023 Feb; 42(7):530-540. PubMed ID: 36539569
[TBL] [Abstract][Full Text] [Related]
60. Evolutionary biologic changes of gut microbiota in an 'adenoma-carcinoma sequence' mouse colorectal cancer model induced by 1, 2-Dimethylhydrazine.
Sun T; Liu S; Zhou Y; Yao Z; Zhang D; Cao S; Wei Z; Tan B; Li Y; Lian Z; Wang S
Oncotarget; 2017 Jan; 8(1):444-457. PubMed ID: 27880935
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
